2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
No abstract available

Keywords: Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar.

Publication types

  • Practice Guideline

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / therapy*
  • Algorithms
  • Angina Pectoris / etiology
  • Anticoagulants / therapeutic use
  • Biomarkers / metabolism
  • Cardiotonic Agents / therapeutic use
  • Coronary Angiography / methods
  • Diagnosis, Differential
  • Electrocardiography
  • Hemorrhage / prevention & control
  • Humans
  • Long-Term Care
  • Non-ST Elevated Myocardial Infarction / diagnosis
  • Non-ST Elevated Myocardial Infarction / therapy*
  • Percutaneous Coronary Intervention / methods
  • Physical Examination / methods
  • Platelet Aggregation Inhibitors / therapeutic use
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Purinergic P2Y Receptor Antagonists / therapeutic use
  • Risk Assessment / methods

Substances

  • Anticoagulants
  • Biomarkers
  • Cardiotonic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Purinergic P2Y Receptor Antagonists